Patents by Inventor Faraia Shah

Faraia Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Measurement of cytoskeletal proteins and uses thereof in diagnosis, prognosis and therapy
    Patent number: 9404931
    Abstract: The present invention relates to monitoring patients for an inflammatory condition or infection (preferably wound infection) by testing an extracellular fluid such as a wound fluid for an elevated level of: (i) vimentin; (ii) a vimentin breakdown product; or (iii) a marker indicative of the presence of vimentin. The present invention provides methods of diagnosis and prognosis, wound dressings, devices (e.g. biosensors) and kits for use in such methods.
    Type: Grant
    Filed: December 11, 2006
    Date of Patent: August 2, 2016
    Assignee: Woundchek Laboratories (US), Inc.
    Inventors: Faraia Shah, Rachael Clark, Patrick John Trotter, Paul William Watt, Breda Mary Cullen
  • Diagnosis and prognosis of wound infection by measurement of a phospholipase Ain wound fluid
    Patent number: 8685639
    Abstract: The present invention relates to the diagnosis, prognosis and/or treatment of wound infection by testing wound fluid for the presence of a marker which is present in an amount which is indicative of infection. The marker may be high molecular weight phospholipase A2 (cPLA2) or a marker which is correlated with cPLA2.
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: April 1, 2014
    Assignee: Woundcheck Laboratories (US), Inc.
    Inventors: Faraia Shah, Rachael Clark, Patrick John Trotter, Paul William Watt, Breda Mary Cullen
  • DIAGNOSIS AND PROGNOSIS OF WOUND INFECTION BY MEASUREMENT OF A PHOSPHOLIPASE A2 IN WOUND FLUID
    Publication number: 20070231380
    Abstract: The present invention relates to the diagnosis, prognosis and/or treatment of wound infection by testing wound fluid for the presence of a marker which is present in an amount which is indicative of infection. The marker may be high molecular weight phospholipase A2 (cPLA2) or a marker which is correlated with cPLA2.
    Type: Application
    Filed: December 11, 2006
    Publication date: October 4, 2007
    Inventors: Faraia Shah, Rachael Clark, Patrick Trotter, Paul Watt, Breda Cullen
  • MEASUREMENT OF CYTOSKELETAL PROTEINS AND USES THEREOF IN DIAGNOSIS, PROGNOSIS AND THERAPY
    Publication number: 20070141131
    Abstract: The present invention relates to monitoring patients for an inflammatory condition or infection (preferably wound infection) by testing an extracellular fluid such as a wound fluid for an elevated level of: (i) vimentin; (ii) a vimentin breakdown product; or (iii) a marker indicative of the presence of vimentin. The present invention provides methods of diagnosis and prognosis, wound dressings, devices (e.g. biosensors) and kits for use in such methods.
    Type: Application
    Filed: December 11, 2006
    Publication date: June 21, 2007
    Inventors: Faraia Shah, Rachael Clark, Partick Trotter, Paul Watt, Breda Cullen